Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novartis AG ADR sell The Goldman Sachs Group, Inc.

Start price
€106.50
12.09.25 / 50%
Target price
€100.61
12.09.26
Performance (%)
6.10%
Price
€113.00
17:07
Summary
This prediction is currently active. With a performance of 6.10%, the SELL prediction by The_Goldman_Sachs_Gr for Novartis AG ADR is trending in the wrong direction This prediction currently runs until 12.09.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Novartis AG ADR -1.322% -1.322%
iShares Core DAX® -2.465% 2.641%
iShares Nasdaq 100 -2.812% 3.120%
iShares Nikkei 225® -0.345% 6.386%
iShares S&P 500 -2.640% 1.894%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Novartis AG ADR diskutieren
Prediction Sell
Perf. (%) 6.10%
Target price 100.607
Change
Ends at 12.09.26

Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat

Stopped prediction by The_Goldman_Sachs_Gr for Novartis AG ADR

buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€92.80
30.05.24
€110.78
30.05.25
9.91%
31.05.25